Home/Investors/Casdin Capital

Casdin Capital

Biotech Investor · 3 portfolio companies

Portfolio

3

Combined Value

$6.1B

Focus Areas

9

Top Stage

Phase 2

Investment Focus

Renal Metabolic Neuromuscular Rare Diseases Oncology Neurology Cardiology Prenatal Health Genetic Diseases

Portfolio Companies

Company	Stage	Valuation	Focus
Maze Therapeutics	Phase 2	$2.3B	Renal, Metabolic
GeneDx Holdings	Commercial	$2.0B	Rare Diseases, Oncology
Relay Therapeutics	Phase 2	$1.8B	Oncology, Genetic Diseases

Frequent Co-Investors

Third Rock Ventures2 shared Atlas Venture1 shared Arch Venture Partners1 shared BVF Partners1 shared Deerfield Management1 shared Matrix Capital Management1 shared a16z (Andreessen Horowitz)1 shared Alexandria Venture Investments1 shared